; (2) impose any cost-sharing requirement in excess of the lesser of, per 30-day supply— (A) $25; or (B) the amount equal to 25 percent of the negotiated price of the selected insulin product net of all price concessions received by or on behalf of the plan, including price concessions received by or on behalf of third-party entities providing services to the plan, such as pharmacy benefit management services